期刊文献+

真菌败血症17例回顾性临床分析 被引量:15

Fungemia:A Retrospective Clinical Analysis of 17 Patients
下载PDF
导出
摘要 目的 分析真菌败血症可能的一些相关因素,进一步探讨真菌败血症的防治措施。方法 对1995-2004年间医院诊断的真菌败血症17例进行回顾性临床分析。结果真菌败血症占10年间医院所有诊断败血症的5。52%;17例患者中主要菌种为热带念珠菌和白色念珠菌,有6例患者局部病灶真菌培养阳性;气管切开机械通气(47.06%),留置尿管(41.18%)、留置静脉导管及体腔引流管(41。18%)、持续使用广谱抗菌药物(76。47%)、化疗(17.65%)、进入ICU治疗(29.41%)及粒细胞减少(29.41%)为可能相关因素;死亡率70。59%。结论 非白色念珠菌属感染比例增多,中心静脉插管与深部真菌感染相关性可能更强,应早期开始经验性治疗,目前临床应用氟康唑抗真菌治疗剂量偏小。 OBJECTIVE To analyze predisposing factors and investigate the measures to fungemia. METHODS The clinical features, therapy and outcome of 17 patients with fungemia which happened from 1995 to 2004 were retrospectively reviewed. RESULTS The morbidity of fungemia was 5.52~ in all septicemia in our hospital. Can- dida tropicalis and C. albicans were the major fungal species. There were 6 patients found cultured fungi on local loci. Tracheotomy and mechanical ventilation (47. 06%), indwelling urinary catheter (41. 18%), indwelling central venous catheter and drainage tube (41. 18%), persisted use of broad spectrum antibiotic (76. 47%), chemical therapy (17.65%), admission to ICU (29.41%), and neutropenia (29.41%) might be the predisposing factors. The mortality of fungemia was 70.59%. CONCLUSIONS The morbidity of non-C, albicans fungemia is increasing, preemptic therapy should be begun earlier. Higher dose of fluconazole may be recommended in clinical usage.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2006年第11期1241-1243,共3页 Chinese Journal of Nosocomiology
关键词 真菌败血症 预防治疗 氟康唑 Fungemia Prophylaxis Fluconazole
  • 相关文献

参考文献6

  • 1Asmundsdottir LR,Erlendsdottir H,Gottfredsson M.Improving survival of patients with candidaemia:analysis of prognostic factors from a long-term,nationwide study in Iceland[J].Scand J Infect Dis,2005,37(2):111-120.
  • 2Almirante B,Rodriguez D,Park BJ,et al.Epidemiology and predictors of mortality in cases of Candida bloodstream infection:results from population-based surveillance,Barcelona,Spain,from 2002 to 2003[J].J Clin Microbiol,2005,43(4):1829-1835.
  • 3Marco F,Danes C,Almela M,et al.Trends in frequency and in vitro susceptibilities to antifungal agents,including voriconazole and anidulafungin,of Candida bloodstream isolates.Results from a six-year study (1996-2001)[J].Diagn Microbiol Infect Dis,2003,46(4):259-264.
  • 4Peman J,Canton E,Gobernado M,et al.Epidemiology and antifungal susceptibility of Candida species isolated from blood:results of a 2-year multicentre study in Spain[J].Eur J Clin Microbiol Infect Dis,2005,24(1):23-30.
  • 5Torres HA,Kontoyiannis DP,Rolston KV.High-dose fluconazole therapy for cancer patients with solid tumors and support care[J].Cancer,2004,12(7):511-516.
  • 6Piarroux R,Grenouillet F,Balvay P,et al.Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients[J].Crit Care Med,2004,32(12):2443-2449.

同被引文献93

引证文献15

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部